🇺🇸 Sulphadoxine-Pyrimethamine in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 2 reports (16.67%)
  2. Spina Bifida — 2 reports (16.67%)
  3. Abasia — 1 report (8.33%)
  4. Blood Sodium Decreased — 1 report (8.33%)
  5. Confusional State — 1 report (8.33%)
  6. Diarrhoea — 1 report (8.33%)
  7. General Physical Health Deterioration — 1 report (8.33%)
  8. Haemoglobin Decreased — 1 report (8.33%)
  9. Hyperkalaemia — 1 report (8.33%)
  10. Platelet Count Decreased — 1 report (8.33%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Sulphadoxine-Pyrimethamine approved in United States?

Sulphadoxine-Pyrimethamine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sulphadoxine-Pyrimethamine in United States?

ORIYOMI OMOTOYOSI AKINYOTU is the originator. The local marketing authorisation holder may differ — check the official source linked above.